Clinical Trials Directory

Trials / Completed

CompletedNCT03852693

Distant Metastases and Long-Term Survival After Complete Resection of Neuroendocrine Tumors of the Appendix

Distant Metastases and Long-Term Survival After Complete Resection of Neuroendocrine Tumors of the Appendix: An International Multicenter Study

Status
Completed
Phase
Study type
Observational
Enrollment
278 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of the present project is to evaluate the frequency of distant metastases and clinically relevant relapse and mortality, respectively, of aNEN (Neuroendocrine Neoplasms of the Appendix) measuring 1 - 2 cm. The investigators hypothesize that the mortality rate of aNET (Neuroendocrine Tumors of the Appendix) measuring 1 - 2cm is less than 1%. Furthermore, the investigators hypothesize that regional lymph node metastases of aNET measuring 1 - 2 cm are clinically not relevant and are not associated with reduced survival. The investigators therefore hypothesize that oncological right-sided hemicolectomy has no impact on long-term survival after complete resection of aNET measuring 1 - 2 cm and that the malignant potential quo ad vitam of these tumors is lower than the risk of oncological hemicolectomy.

Conditions

Interventions

TypeNameDescription
OTHERHistopathological reviewHistopathological review

Timeline

Start date
2020-10-01
Primary completion
2022-08-30
Completion
2022-08-30
First posted
2019-02-25
Last updated
2024-11-13

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03852693. Inclusion in this directory is not an endorsement.